DSN sat down with Scott Melville, CHPA president and CEO, to discuss the Consumer Healthcare Products Association 2013 Annual Executive Conference and how the conference will focus on "consumer centricity," in this exclusive podcast. In addition, senior-level executives attending the sold-out conference will learn how CHPA is extolling that value on Capitol Hill. "OTCs are demonstrating their value everyday because consumers are purchasing them with their own dollars," Melville said. "The challenge has been for policy-makers to understand the value that OTC medicines bring." But that may change this year, Melville said, as CHPA continues to lobby around that OTC value quotient.
"Game change." That's the theme leading up to the Consumer Healthcare Products Association's 2012 Annual Executive Conference given the shifts in consumer demand and legislative focus. DSN caught up with CHPA's president and CEO Scott Melville before the meeting to get a sense of where the business of consumer healthcare products stands today, and what the association is working toward tomorrow.
Is this the year that restrictions on the use of over-the-counter medicines in conjunction with a flexible savings account are lifted? If you consider the value proposition — the $102 billion saved each year by the use of OTC medicines — and that health care is moving toward a more value-based, outcomes-driven system, it would certainly seem so.
In preparation for the Consumer Healthcare Products Association’s 2015 Annual Executive Conference being held in Bonita Springs, Fla., this month, Drug Store News sat down with both Scott Melville, CHPA president and CEO, and Patrick Lockwood-Taylor, CHPA chair and VP personal health care, North America, for Procter & Gamble.
The Consumer Healthcare Products Association urged the president to support changing the mandate that consumers obtain a prescription in order to utilize FSAs and HSAs to purchase over-the-counter medicines.
Themed, "20-20 Vision," the 2014 Consumer Health Products Association held its Annual Executive Conference, March 17 to 19, at the Ritz Carlton in Amelia Island, Fla. "Predicting the future is never easy, but a clear-eyed view of the landscape does sharpen our ability to see where the road is going," CHPA president and CEO Scott Melville told attendees of this year's event.
The Consumer Healthcare Products Association on Tuesday awarded the Ivan D. Combe Lifetime Achievement Award to George Quesnelle, former president, North America, Consumer Healthcare, GlaxoSmithKline, during the association’s Annual Executive Conference.
The Consumer Healthcare Products Association this year will be focusing on restoring OTC eligibility under flexible spending accounts and helping to finalize OTC monographs, Scott Melville, CHPA president and CEO, told attendees of the 2014 CHPA Annual Executive Conference Tuesday morning.
Abuse of the cough ingredient dextromethorphan among high school seniors is down, according to this year’s Monitoring the Future survey, which measures drug use and attitudes among the nation’s eighth-, 10th- and 12th-graders.
The Consumer Healthcare Products Association on Friday submitted a letter to U.S. Treasury Secretary Jacob Lew, thanking the Administration for its recent efforts to enhance flexible savings arrangements’ benefits, the association announced.
U.S. Sens. Pat Roberts, R-Kan., and Mary Landrieu, D-La., on Tuesday introduced legislation that repeals a portion of Obamacare that prohibits people from using their medical savings account funds to buy over-the-counter medications.
The Consumer Healthcare Products Association joined Indiana Attorney General Greg Zoeller, state Rep. Larry Bucshon, as well as local officials and leaders from the Indiana Pharmacists Alliance, the Indiana Prosecuting Attorneys Council, the Indiana Retail Council and the Community Anti-Drug Coalitions of America, at a press conference to launch the state’s new voluntary retail Anti-Smurfing Campaign.
The Consumer Healthcare Products Association on Wednesay applauded Delaware Rep. Rebecca Walker, the Delaware legislature and Gov. Jack Markell for passing and signing House Bill 130, an anti-methamphetamine bill.
Pennsylvania last month became the 29th state to employ the National Precursor Log Exchange in the fight against the diversion of products containing pseudoephedrine into methamphetamine. State No. 30, Delaware, is expected to sign real-time stop sale technology into law this summer.
Sens. Bob Casey, D-Pa., and Lisa Murkowski, R-Ark., on Friday introduced the Preventing Abuse of Cough Treatments Act of 2013, which would require retailers to restrict the sale of dextromethorphan-containing products to adults.
The Consumer Healthcare Products Association's Annual Executive Conference was sold out for the first time since 2001, CHPA president and CEO Scott Melville told a packed morning session, and that is a strong prognosticator as to the health and vitality of the self-care industry.
Nearly 98% of primary care physicians, nurse practitioners and pharmacists trust and recommend over-the-counter medicines to their patients, according to a new survey released Wednesday by the Consumer Healthcare Products Association.